$4.13
0.24%
Nasdaq, Sep 17, 04:00 pm EDT. Closed.
ISIN
US38870X1046
Symbol
LENZ

Graphite Bio Inc Target price 2026 - Analyst rating & recommendation

Graphite Bio Inc Classifications & Recommendation

Buy
77%
Hold
23%

Graphite Bio Inc Price Target

Target Price $10.20
Price $4.13
Potential
Number of Estimates 8
8 Analysts have issued a price target Graphite Bio Inc 2027 . The average Graphite Bio Inc target price is $10.20. This is higher than the current stock price. The highest price target is
$63.00 1,425.42%
register free of charge
, the lowest is .
A rating was issued by 13 analysts: 10 Analysts recommend Graphite Bio Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Graphite Bio Inc stock has an average upside potential 2027 of . Most analysts recommend the Graphite Bio Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 19.09 17.65
7.55%
EBITDA Margin -475.90% -644.23%
35.37%
Net Margin -430.23% -741.91%
72.45%

9 Analysts have issued a sales forecast Graphite Bio Inc 2026 . The average Graphite Bio Inc sales estimate is

$17.6m
unlock
. This is
17.84% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$24.0m 11.94%
unlock
, the lowest is
$13.4m 37.59%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $19.1m
2026
$17.6m 7.55%
unlock
2027
$43.9m 148.46%
unlock
2028
$107m 144.35%
unlock
2029
$270m 151.64%
unlock
2030
$358m 32.62%
unlock
2031
$470m 31.44%
unlock
2032
$525m 11.67%
unlock
2033
$568m 8.21%
unlock

4 Analysts have issued an Graphite Bio Inc EBITDA forecast 2026. The average Graphite Bio Inc EBITDA estimate is

$-114m
unlock
. This is
15.90% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-114m 15.65%
unlock
, the lowest is
$-112m 17.13%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-90.9m 55.17%
2026
$-114m 25.15%
unlock
2027
$-62.1m 45.38%
unlock
2028
$-87.5m 40.87%
unlock

EBITDA Margin

2025 -475.90%
2026
-644.23% 35.37%
unlock
2027
-141.61% 78.02%
unlock
2028
-81.64% 42.35%
unlock

9 Graphite Bio Inc Analysts have issued a net profit forecast 2026. The average Graphite Bio Inc net profit estimate is

$-131m
unlock
. This is
3.92% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-125m 1.02%
unlock
, the lowest is
$-137m 8.75%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-82.1m 65.02%
2026
$-131m 59.43%
unlock
2027
$-87.0m 33.53%
unlock
2028
$-60.6m 30.39%
unlock
2029
$45.2m 174.58%
unlock
2030
$102m 125.87%
unlock
2031
$158m 54.80%
unlock
2032
$160m 1.28%
unlock
2033
$178m 11.21%
unlock

Net Margin

2025 -430.23%
2026
-741.91% 72.45%
unlock
2027
-198.50% 73.24%
unlock
2028
-56.55% 71.51%
unlock
2029
16.76% 129.64%
unlock
2030
28.55% 70.35%
unlock
2031
33.62% 17.76%
unlock
2032
30.49% 9.31%
unlock
2033
31.33% 2.76%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -2.85 -4.17
21.79% 46.32%
P/E negative
EV/Sales negative

9 Analysts have issued a Graphite Bio Inc forecast for earnings per share. The average Graphite Bio Inc EPS is

$-4.17
unlock
. This is
3.99% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-3.97 1.00%
unlock
, the lowest is
$-4.36 8.73%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-2.85 21.79%
2026
$-4.17 46.32%
unlock
2027
$-2.77 33.57%
unlock
2028
$-1.93 30.32%
unlock
2029
$1.44 174.61%
unlock
2030
$3.25 125.69%
unlock
2031
$5.03 54.77%
unlock
2032
$5.09 1.19%
unlock
2033
$5.66 11.20%
unlock

P/E ratio

Current -1.03 95.35%
2026
-0.99 4.11%
unlock
2027
-1.49 50.51%
unlock
2028
-2.15 44.30%
unlock
2029
2.88 233.95%
unlock
2030
1.27 55.90%
unlock
2031
0.82 35.43%
unlock
2032
0.81 1.22%
unlock
2033
0.73 9.88%
unlock

Based on analysts' sales estimates for 2026, the Graphite Bio Inc stock is valued at an EV/Sales of

-5.09
unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -4.19 102.16%
2026
-5.09 21.60%
unlock
2027
-2.05 59.75%
unlock
2028
-0.84 59.08%
unlock
2029
-0.33 60.26%
unlock
2030
-0.25 24.59%
unlock
2031
-0.19 23.94%
unlock
2032
-0.17 10.45%
unlock
2033
-0.16 7.59%
unlock

P/S ratio

Current 6.06 97.43%
2026
7.37 21.71%
unlock
2027
2.97 59.75%
unlock
2028
1.21 59.07%
unlock
2029
0.48 60.26%
unlock
2030
0.36 24.59%
unlock
2031
0.28 23.91%
unlock
2032
0.25 10.48%
unlock
2033
0.23 7.59%
unlock

Current Graphite Bio Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked Aug 12 2026
HC Wainwright & Co.
Locked
Locked
Locked Jul 07 2026
Citigroup
Locked
Locked
Locked May 13 2026
Piper Sandler
Locked
Locked
Locked May 12 2026
HC Wainwright & Co.
Locked
Locked
Locked May 12 2026
HC Wainwright & Co.
Locked
Locked
Locked Apr 21 2026
Citigroup
Locked
Locked
Locked Mar 26 2026
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
Aug 12 2026
Locked
HC Wainwright & Co.:
Locked
Locked
Jul 07 2026
Locked
Citigroup:
Locked
Locked
May 13 2026
Locked
Piper Sandler:
Locked
Locked
May 12 2026
Locked
HC Wainwright & Co.:
Locked
Locked
May 12 2026
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 21 2026
Locked
Citigroup:
Locked
Locked
Mar 26 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today